122 related articles for article (PubMed ID: 22414283)
1. Recursive partitioning analysis for new classification of patients with esophageal cancer treated by chemoradiotherapy.
Nomura M; Shitara K; Kodaira T; Kondoh C; Takahari D; Ura T; Kojima H; Kamata M; Muro K; Sawada S
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):786-92. PubMed ID: 22414283
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578
[TBL] [Abstract][Full Text] [Related]
3. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
[TBL] [Abstract][Full Text] [Related]
4. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
5. Developing an appropriate staging system for esophageal carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
7. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.
Hsu PK; Wu YC; Chou TY; Huang CS; Hsu WH
Ann Thorac Surg; 2010 Apr; 89(4):1024-31. PubMed ID: 20338302
[TBL] [Abstract][Full Text] [Related]
9. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
10. Proposed Modification of Nodal Staging as an Alternative to the Seventh Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Improves the Prognostic Prediction in the Resected Esophageal Squamous-Cell Carcinoma.
Ning ZH; Wang ZG; Chen J; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
J Thorac Oncol; 2015 Jul; 10(7):1091-8. PubMed ID: 26134226
[TBL] [Abstract][Full Text] [Related]
11. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
Fang WT; Feng J; Mao T; Fu SJ; Chen WH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
[TBL] [Abstract][Full Text] [Related]
12. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.
Rizk N; Venkatraman E; Park B; Flores R; Bains MS; Rusch V;
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1374-81. PubMed ID: 17140960
[TBL] [Abstract][Full Text] [Related]
13. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
14. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
15. The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.
Akutsu Y; Shuto K; Kono T; Uesato M; Hoshino I; Shiratori T; Isozaki Y; Akanuma N; Uno T; Matsubara H
J Surg Oncol; 2012 Jun; 105(8):756-60. PubMed ID: 22162007
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma.
Yan HJ; Wang RB; Zhu KL; Jiang SM; Zhao W; Xu XQ; Feng R
Chin Med J (Engl); 2012 Apr; 125(8):1410-5. PubMed ID: 22613644
[TBL] [Abstract][Full Text] [Related]
17. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System.
D'Annoville T; D'Journo XB; Loundou A; Trousse D; Dahan L; Doddoli C; Seitz JF; Thomas PA
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e207-11; discussion e211. PubMed ID: 23818566
[TBL] [Abstract][Full Text] [Related]
19. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]